4X5W image
Deposition Date 2014-12-06
Release Date 2016-03-09
Last Version Date 2024-11-13
Entry Detail
PDB ID:
4X5W
Keywords:
Title:
HLA-DR1 with CLIP102-120(M107W)
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Method Details:
Experimental Method:
Resolution:
1.34 Å
R-Value Free:
0.17
R-Value Work:
0.14
R-Value Observed:
0.14
Space Group:
C 2 2 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HLA class II histocompatibility antigen, DR alpha chain
Gene (Uniprot):HLA-DRA
Chain IDs:A
Chain Length:193
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:HLA class II histocompatibility antigen, DRB1-1 beta chain
Chain IDs:B
Chain Length:199
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:HLA class II histocompatibility antigen gamma chain
Gene (Uniprot):CD74
Mutations:M107W
Chain IDs:C
Chain Length:19
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
MHC class II complexes sample intermediate states along the peptide exchange pathway.
Nat Commun 7 13224 13224 (2016)
PMID: 27827392 DOI: 10.1038/ncomms13224

Abstact

The presentation of peptide-MHCII complexes (pMHCIIs) for surveillance by T cells is a well-known immunological concept in vertebrates, yet the conformational dynamics of antigen exchange remain elusive. By combining NMR-detected H/D exchange with Markov modelling analysis of an aggregate of 275 microseconds molecular dynamics simulations, we reveal that a stable pMHCII spontaneously samples intermediate conformations relevant for peptide exchange. More specifically, we observe two major peptide exchange pathways: the kinetic stability of a pMHCII's ground state defines its propensity for intrinsic peptide exchange, while the population of a rare, intermediate conformation correlates with the propensity of the HLA-DM-catalysed pathway. Helix-destabilizing mutants designed based on our model shift the exchange behaviour towards the HLA-DM-catalysed pathway and further allow us to conceptualize how allelic variation can shape an individual's MHC restricted immune response.

Legend

Protein

Chemical

Disease

Primary Citation of related structures